Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 46% ± 26% | |
oligodendrocyte precursor cell | 8 studies | 29% ± 13% | |
retinal cone cell | 6 studies | 50% ± 21% | |
GABAergic neuron | 6 studies | 44% ± 20% | |
astrocyte | 4 studies | 35% ± 16% | |
GABAergic interneuron | 3 studies | 23% ± 3% | |
interneuron | 3 studies | 42% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 42% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 370.56 | 2468 / 2642 | 71% | 3.57 | 499 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.08 | 1 / 1 |
spleen | 88% | 86.73 | 213 / 241 | 0% | 0 | 0 / 0 |
ovary | 78% | 64.06 | 140 / 180 | 1% | 0.03 | 6 / 430 |
adrenal gland | 10% | 6.39 | 26 / 258 | 56% | 7.12 | 129 / 230 |
breast | 5% | 1.85 | 21 / 459 | 39% | 0.97 | 440 / 1118 |
pancreas | 23% | 10.05 | 75 / 328 | 15% | 0.38 | 26 / 178 |
bladder | 0% | 0 | 0 / 21 | 34% | 1.22 | 173 / 504 |
esophagus | 27% | 19.90 | 395 / 1445 | 5% | 0.22 | 10 / 183 |
intestine | 4% | 1.80 | 40 / 966 | 14% | 0.42 | 74 / 527 |
peripheral blood | 17% | 11.92 | 157 / 929 | 0% | 0 | 0 / 0 |
uterus | 5% | 2.72 | 9 / 170 | 11% | 0.39 | 52 / 459 |
stomach | 1% | 0.45 | 4 / 359 | 11% | 0.43 | 31 / 286 |
thymus | 1% | 0.40 | 4 / 653 | 11% | 0.36 | 67 / 605 |
prostate | 0% | 0 | 0 / 245 | 7% | 0.12 | 33 / 502 |
lung | 0% | 0 | 0 / 578 | 6% | 0.25 | 69 / 1155 |
skin | 2% | 0.86 | 39 / 1809 | 2% | 0.06 | 11 / 472 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 0.17 | 3 / 80 |
liver | 0% | 0 | 0 / 226 | 3% | 0.08 | 14 / 406 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.15 | 29 / 901 |
muscle | 1% | 0.93 | 10 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.12 | 4 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0099175 | Biological process | regulation of postsynapse organization |
GO_0009986 | Cellular component | cell surface |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0098793 | Cellular component | presynapse |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
Gene name | LRFN2 |
Protein name | Leucine rich repeat and fibronectin type III domain containing 2 Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1) |
Synonyms | SALM1 KIAA1246 |
Description | FUNCTION: Promotes neurite outgrowth in hippocampal neurons. Enhances the cell surface expression of 2 NMDA receptor subunits GRIN1 and GRIN2A. May play a role in redistributing DLG4 to the cell periphery (By similarity). . |
Accessions | A0A8V8TQ63 ENST00000338305.7 Q9ULH4 ENST00000700335.1 |